Quality of Life After Permanent Interstitial Iodine Seed Prostate Brachytherapy

December 11, 2016 updated by: Daniel Rudolf Zwahlen, Kantonsspital Graubuenden

Retrospective Analysis of Quality of Life After Permanent Interstitial Iodine Seed Brachytherapy for Prostate Cancer

Retrospective study to analyze Quality of life in men after iodine seed brachytherapy for localized prostate cancer

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Retrospective Evaluation of Quality of life data collected on men who underwent iodine seed brachytherapy at the University Hospital Zurich

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Switzerland
      • Chur, Switzerland, 7000
        • Kantonsspital Graubuenden, Department of Radiaton Oncology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

48 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

Patients having had idodine seed brachytherapy for localized prostate cancer between 2009 and 2014

Description

Inclusion Criteria:

  • Male > 18 years of age
  • iodine seed brachytherapy for localized prostate cancer at the University Hospital Zurich

Exclusion Criteria:

  • No iodine seed brachytherapy for localized prostate cancer at the University Hospital Zurich

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
CTCAE v4.03ff Grade 1-4 Sexual/Reproductive Function
Time Frame: 5 years (2009-2014)
Scale
5 years (2009-2014)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
CTCAE v4.03ff Grade 1-4 Gastrointestinal
Time Frame: 5 years (2009-2014)
Scale
5 years (2009-2014)
CTCAE v4.03ff Grade 1-4 Renal/Genitourinary
Time Frame: 5 years (2009-2014)
Scale
5 years (2009-2014)
International Prostate Symptom Score (IPSS)
Time Frame: 5 years (2009-2014)
Scale
5 years (2009-2014)
International Index of erectile function, five items (IIEF-5)
Time Frame: 5 years (2009-2014)
Scale
5 years (2009-2014)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kantonsspital Graubuenden

Collaborators

University of Zurich

Investigators

  • Principal Investigator: Daniel R Zwahlen, MD, MBA, Kantonsspital Graubuenden

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2009

Primary Completion (Actual)

December 1, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

January 6, 2016

First Submitted That Met QC Criteria

January 7, 2016

First Posted (Estimate)

January 11, 2016

Study Record Updates

Last Update Posted (Estimate)

December 13, 2016

Last Update Submitted That Met QC Criteria

December 11, 2016

Last Verified

December 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KEK-ZH-Nr. 2015-0573

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neoplasms, Prostate

Clinical Trials on No intervention in this retrospective study

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe